Skip to main content
Home Home

User account menu

  • Log in

Main navigation

  • Home
  • Topics
    • Antimicrobials
    • Asthma
    • Biological medicines
    • COVID-19 medicines
    • Cardiovascular disease
    • Equity
    • Focus medicines
    • Gout
    • Hepatitis C
    • Menopause
    • Type 2 diabetes
    • Youth mental health
  • Resources
    • All education/search
    • Brand changes
    • Clinical articles
    • HAH Bulletins
    • Podcasts
    • Recorded webinars
    • Reflect & audit activities
    • Resource hubs
    • Videos
  • EPiC dashboard
    • Go to EPiC
    • Join EPiC
    • EPiC FAQ
    • EPiC Demo
    • About EPiC
  • News
    • Events
    • That's Interesting
    • From The Team

Education

  1. Home
  2. Search

The hub for all your learning resources.

Here you will find all our clinical education resources from articles to recorded webinars, all supporting equitable access to funded medicines.

EPiC dashboard
This item is over 2 years old; some content may no longer be current

EPiC user guide

This guide highlights the different features in EPiC, helping you to navigate through the dashboard. Our worked example shows how EPiC can be used to carry out quality improvement activities. 

View online or click the print-ready version.

Contributor
Dr Noni Richards
20 July 2022
  • EPiC
Quinapril image
This item is over 2 years old; some content may no longer be current

Transitioning people off Accuretic

5 minutes to Read

The antihypertensive medicine Accuretic (quinapril with hydrochlorothiazide) is being withdrawn (Pfizer pulled stock from distribution on 31 October 2022).

Prescribers are advised to change patients from Accuretic to alternative medicine(s) with some urgency. Read our article for dose equivalence tables and information on switching, monitoring, co-payments and consultation fees.

Contributor
Dr Noni Richards
4 July 2022
  • CVD
  • Clinical article
Bulletin 15
This item is over 2 years old; some content may no longer be current

Secondary prevention of CVD

1 minute to Read

Although triple therapy can reduce the risk of recurrent CVD events by at least 50 per cent over five years, the He Ako Hiringa EPiC dashboard indicates only half of people receive all three types of medicines following a CVD event. Read our latest bulletin for more on triple therapy and team-based initiatives that may help identify and prioritise patients for intensive management.

Contributor
He Ako Hiringa
1 July 2022
  • HAH Bulletins
  • CVD
Adalimumab Q&A
This item is over 2 years old; some content may no longer be current

Adalimumab Q&A

With recent funding changes to adalimumab, prescribers are being urged to change patients from Humira (the reference biological) to Amgevita (a biosimilar). We’ve collated this list of questions and answers, with links to other useful resources, to help inform your conversations with colleagues and patients.

Contributor
He Ako Hiringa
16 June 2022
  • Biological medicines
Focus magazine
This item is over 2 years old; some content may no longer be current

FOCUS magazine

FOCUS magazine showcases a selection of our original resources. You can use the educational content featured in FOCUS to identify and reduce barriers that prevent people from accessing the medicines they need.

Contributor
He Ako Hiringa
16 June 2022
  • Equity
  • Gout
  • Diabetes
  • EPiC
EPiC Reflect & Audit CVD
This item is over 2 years old; some content may no longer be current

EPiC Reflect & Audit - CVD

This editable PDF helps you to delve into the EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions. 

*New audit section*
An additional audit/CQI section allows you or your practice team to repeat the process, completing activities that may be used for Foundation Standard or the Cornerstone CQI or Equity modules.

Contributor
He Ako Hiringa
9 June 2022
  • Reflect & audit activities
  • CVD
  • EPiC
Bulletin 14
This item is over 2 years old; some content may no longer be current

Health managers influencing equitable outcomes

1 minute to Read

Managers within healthcare provider services are vital to leading activity that promotes achieving equity of outcomes. Genuine management guidance is crucial to reduce bias and improve the health experience for individuals, whānau, and our communities.

Contributor
Josephine Davis
1 June 2022
  • HAH Bulletins
  • Equity
Bulletin 13
This item is over 2 years old; some content may no longer be current

New antiviral targets COVID-19 

1 minute to Read

Nirmatrelvir with ritonavir (Paxlovid), a new oral antiviral medicine for adults with COVID-19, is now available for community use. In people at higher risk of severe illness from COVID-19, treatment with Paxlovid has been shown to reduce the incidence of hospitalisation or death. However, for certain patients it will not be safe or appropriate to use Paxlovid.

Contributor
He Ako Hiringa
2 May 2022
  • HAH Bulletins
  • COVID-19
CVD workbook
This item is over 2 years old; some content may no longer be current

CVD Workbook: Understanding and communicating CVD risk and management recommendations

4 minutes to Read + 56 minutes to Delve

This workbook consists of introductory reading and five distinct modules that encourage you to reflect on your CVD risk assessment and management practices, risk communication, cultural safety, and your engagement with young adult Māori and Pacific patients.

Contributor
Richard French, Dr Noni Richards
21 April 2022
  • CVD
  • Reflect & audit activities
  • Equity
  • Clinical article
EPiC Reflect and Audit Gout
This item is over 2 years old; some content may no longer be current

EPiC Reflect & Audit - Gout

This editable PDF helps you to delve into the EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions. 

*New audit section*
An additional audit/CQI section allows you or your practice team to repeat the process, completing activities that may be used for Foundation Standard or the Cornerstone CQI or Equity modules.

Contributor
He Ako Hiringa
20 April 2022
  • Reflect & audit activities
  • Gout
  • EPiC
EPiC Reflect Diabetes with audit
This item is over 2 years old; some content may no longer be current

EPiC Reflect & Audit - Diabetes

This editable PDF helps you to delve into the EPiC data, contemplate your prescribing, reflect on your current practice, and set goals and actions. 

*New audit section*
An additional audit/CQI section allows you or your practice team to repeat the process, completing activities that may be used for Foundation Standard or the Cornerstone CQI or Equity modules.

Contributor
He Ako Hiringa
14 April 2022
  • Reflect & audit activities
  • Diabetes
  • EPiC
This item is over 2 years old; some content may no longer be current

The patient voice: Moving to Amgevita

3 minutes to Watch

This short video explores what patients think about the move to Amgevita. We spoke to a group of seven New Zealanders living with arthritis to find out how they feel about changing from the biological reference medicine, Humira, to the new biosimilar medicine, Amgevita. 

Contributor
He Ako Hiringa
14 April 2022
  • Biological medicines
  • Videos

Pagination

  • « First First page
  • ‹ Previous Previous page
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • Next › Next page
  • Last » Last page
Home Home

Contact Us

Suite B, 2/20 Augustus Terrace, Parnell, Auckland 1052

PO Box 37590, Parnell, Auckland 1151

Support

09 488 4286

admin@akohiringa.co.nz

(9-5pm Mon-Fri)

Contact us

About us

Terms & Policies

  • Conditions for Use

Supported by

Pharmac

© Matui Limited. All rights reserved.

Developed by Matui Limited and brought to life by Communica.